Jeffrey Cohen
Stock Analyst at Ladenburg Thalmann
(0.11)
# 4,486
Out of 5,179 analysts
18
Total ratings
15.38%
Success rate
-32.35%
Average return
Main Sectors:
Stocks Rated by Jeffrey Cohen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HROW Harrow | Maintains: Buy | $64 → $66 | $33.83 | +95.09% | 2 | Nov 12, 2025 | |
| CELH Celsius Holdings | Maintains: Neutral | $62 → $58 | $33.94 | +70.89% | 3 | Mar 27, 2025 | |
| ECOR electroCore | Maintains: Buy | $28 → $26 | $5.88 | +342.18% | 2 | Mar 13, 2025 | |
| NUWE Nuwellis | Downgrades: Neutral | n/a | $1.05 | - | 1 | Nov 8, 2023 | |
| SABS SAB Biotherapeutics | Downgrades: Neutral | n/a | $3.85 | - | 1 | Oct 5, 2023 | |
| FBIO Fortress Biotech | Initiates: Buy | $90 | $2.76 | +3,160.87% | 1 | Aug 4, 2022 | |
| OPK OPKO Health | Initiates: Buy | $7 | $1.12 | +525.00% | 1 | Jun 21, 2021 | |
| NNOX Nano-X Imaging | Initiates: Buy | $52 | $2.21 | +2,252.94% | 1 | Apr 19, 2021 | |
| TENX Tenax Therapeutics | Upgrades: Buy | n/a | $14.90 | - | 1 | May 18, 2017 | |
| CNMD CONMED | Downgrades: Neutral | n/a | $34.58 | - | 5 | Apr 27, 2017 |
Harrow
Nov 12, 2025
Maintains: Buy
Price Target: $64 → $66
Current: $33.83
Upside: +95.09%
Celsius Holdings
Mar 27, 2025
Maintains: Neutral
Price Target: $62 → $58
Current: $33.94
Upside: +70.89%
electroCore
Mar 13, 2025
Maintains: Buy
Price Target: $28 → $26
Current: $5.88
Upside: +342.18%
Nuwellis
Nov 8, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.05
Upside: -
SAB Biotherapeutics
Oct 5, 2023
Downgrades: Neutral
Price Target: n/a
Current: $3.85
Upside: -
Fortress Biotech
Aug 4, 2022
Initiates: Buy
Price Target: $90
Current: $2.76
Upside: +3,160.87%
OPKO Health
Jun 21, 2021
Initiates: Buy
Price Target: $7
Current: $1.12
Upside: +525.00%
Nano-X Imaging
Apr 19, 2021
Initiates: Buy
Price Target: $52
Current: $2.21
Upside: +2,252.94%
Tenax Therapeutics
May 18, 2017
Upgrades: Buy
Price Target: n/a
Current: $14.90
Upside: -
CONMED
Apr 27, 2017
Downgrades: Neutral
Price Target: n/a
Current: $34.58
Upside: -